Merck stock’s biggest selloff in nearly 17 years is cutting close to 60 points off the Dow’s price

Posted November 7th, 2021 by Brahm Canzer & filed under Company Analysis, Governments & Regulators, Growth & Valuation, Industry Analysis, Management Issues.

Description: Shares of Merck & Co. MRK, tumbled 9.5% in midday trading Friday, putting them on track to suffer the biggest one-day drop since January 2005, after Pfizer Inc. PFE, released data on a pill to treat COVID-19 that showed greater efficacy than Merck’s.

Source: MarketWatch.com

Date: Nov 05, 2021

Link: https://www.marketwatch.com/story/merck-stocks-biggest-selloff-in-nearly-17-years-is-cutting-close-to-60-points-off-the-dows-price-2021-11-05?mod=home-page

Questions for discussion:

What does the article say to investors who are invested in the pharmaceutical firms fighting Covid?
What would you advise investors do to mitigate risk in this field?